Wealth Enhancement Advisory Services
UTMD icon

Wealth Enhancement Advisory Services’s Utah Medical Products UTMD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$220K Buy
+2,974
New +$212K ﹤0.01% 3658

Other funds holding UTMD

Cardinal Capital Management Inc (North Carolina)
Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $861M AUM 27.19% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Bridge City Capital
Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Seizert Capital Partners
Seizert Capital Partners Birmingham, Michigan $2.3B AUM 16.06% 1-Year Est. Return
Penobscot Investment Management
Penobscot Investment Management Boston, Massachusetts $1.44B AUM 23.59% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Wealth Enhancement Advisory Services's UTMD Position: Q3 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Utah Medical Products (UTMD) in Q3 2026: 2,974 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #3658 among its holdings.

32 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

  • Wealth Enhancement Advisory Services held 2,974 shares of Utah Medical Products worth $220K as of Q3 2026.
  • Utah Medical Products was a new Wealth Enhancement Advisory Services position in Q3 2026.
  • Utah Medical Products made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3658 holding.
  • 32 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.